DENMARK - Vækstfonden invests $ 19.27m in series B round in Egalet
Vækstfonden has invested $19.27m in Egalet, a pharmaceutical company that specialises in oral controlled released products. The investment will be used to expand and optimise its proprietary product portfolio.
More on Expansion
Iconiq Growth leads $530m round for Wolt
New round takes the total amount Wolt has raised to $856m
Limerston-backed Prism acquires Repose
GP bought Prism via its debut fund, Limerston Capital Partners I, which closed in 2017 on £220m
Oakley Capital invests €175m in EQT's Idealista
GP backs the company via Oakley Capital IV, which held a final close on €1.46bn in July 2019
Xplorer Capital, Futury Venture lead $22m round for Wingcopter
Germany-based delivery drone developer is also backed by Hessen Kapital via Hessen Kapital III
Latest News
Sagard buys Nutrisens from Evolem, Unigrains
Nutrisens management team, led by CEO Georges Devesa, retains a significant stake in the company
Litorina-backed Fractal Gaming Group to list
Intention to list comes four years after the GP acquired the company via its fourth fund
VC-backed Mister Spex buys Tribe
Online optician has previously received VC funding from investors including Grazia Equity and Goldman Sachs
Moonfare, Lexington launch digital secondaries platform
Platform will enable smaller investors to put their secondaries stakes up for sale